MIRIKIZUMAB (mir i KIZ ue mab) treats ulcerative colitis. It may also be used to treat Crohn disease. It works by decreasing inflammation in the digestive tract. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.